Skip to main content
DanaherLinkedIn

Rare diseases are often overlooked and underfunded.

Source

LinkedInJan 7, 2026
likes
55
comments
1

Post

Rare diseases are often overlooked and underfunded. Patients endure pills, injections and surgeries without ever addressing the root cause. Even as next-generation sequencing and CRISPR unlock new possibilities, the path from discovery to delivery remains fragmented. The first gene editing therapies have shown promise, but they’re only the beginning. To reach more patients, science must overcome complex scientific, regulatory and logistical barriers. That’s where Danaher comes in. We’re building a connected ecosystem that accelerates breakthroughs and brings life-changing therapies to patients sooner. Explore how we’re charting a bold path forward to turn complexity into clarity and potential into progress: https://lnkd.in/giXuTbhz

linkedin.com/feed/update/urn:li:activity:7414720758196908032Read the full source

Extracted by Autobound

From the Signal API record
Signal
LinkedIn

What this signalsCompany posts often show what the team is pushing right now.

The full record

From the Signal API record

Topics and mentions

Tags

  • Pharmaceuticals
  • Research & Development
  • Regulations
  • Logistics / Supply Chain

Extraction

Detected
Jan 8, 2026
signal_type
linkedin-post-company
signal_subtype
linkedinPost

Use this data

Get every LinkedIn signal for Danaher and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Danaher this week?”

  2. Send it to your own tools

    The Signal API returns LinkedIn signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full linkedin-post-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/a22b6748-dfe1-4267-aa25-ea5d6b9a45db returns this record as JSON. POST /v1/companies/enrich returns every signal for danaher.com.

{
  "signal_id": "a22b6748-dfe1-4267-aa25-ea5d6b9a45db",
  "signal_type": "linkedin-post-company",
  "signal_subtype": "linkedinPost",
  "detected_at": "2026-01-08T12:32:29.55+00:00",
  "company": {
    "name": "Danaher",
    "domain": "danaher.com"
  },
  "data": {
    "tags": [
      "Pharmaceuticals",
      "Research & Development",
      "Regulations",
      "Logistics / Supply Chain"
    ],
    "post_url": "https://www.linkedin.com/feed/update/urn:li:activity:7414720758196908032/",
    "num_likes": 55,
    "post_text": "Rare diseases are often overlooked and underfunded. Patients endure pills, injections and surgeries without ever addressing the root cause. Even as next-generation sequencing and CRISPR unlock new possibilities, the path from discovery to delivery remains fragmented.\n\nThe first gene editing therapies have shown promise, but they’re only the beginning. To reach more patients, science must overcome complex scientific, regulatory and logistical barriers. That’s where Danaher comes in.\n\nWe’re building a connected ecosystem that accelerates breakthroughs and brings life-changing therapies to patients sooner.\n\nExplore how we’re charting a bold path forward to turn complexity into clarity and potential into progress: https://lnkd.in/giXuTbhz",
    "posted_date": "2026-01-07T17:33:07.604Z",
    "num_comments": 1
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.